Short Interest in Cellebrite DI Ltd. (NASDAQ:CLBT) Increases By 13.6%

Cellebrite DI Ltd. (NASDAQ:CLBT) was the recipient of a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 1,170,000 shares, an increase of 13.6% from the December 31st total of 1,030,000 shares. Approximately 1.4% of the shares of the company are short sold. Based on an average daily trading volume, of 1,310,000 shares, the days-to-cover ratio is currently 0.9 days.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Needham & Company LLC upped their price objective on shares of Cellebrite DI from $21.00 to $28.00 and gave the company a “buy” rating in a report on Wednesday, January 22nd. JPMorgan Chase & Co. raised their target price on Cellebrite DI from $22.00 to $24.00 and gave the stock an “overweight” rating in a research note on Monday, December 16th. Finally, Craig Hallum upped their price target on Cellebrite DI from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Eight analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $21.57.

Institutional Investors Weigh In On Cellebrite DI

Institutional investors have recently bought and sold shares of the business. Handelsbanken Fonder AB bought a new stake in Cellebrite DI in the fourth quarter worth $3,937,000. New York State Common Retirement Fund increased its stake in Cellebrite DI by 2.6% in the fourth quarter. New York State Common Retirement Fund now owns 189,599 shares of the company’s stock worth $4,177,000 after purchasing an additional 4,838 shares during the period. Pembroke Management LTD lifted its position in shares of Cellebrite DI by 4.4% during the fourth quarter. Pembroke Management LTD now owns 1,992,432 shares of the company’s stock worth $43,893,000 after purchasing an additional 84,087 shares during the last quarter. Strategic Advisors LLC lifted its holdings in Cellebrite DI by 3.4% during the 4th quarter. Strategic Advisors LLC now owns 29,082 shares of the company’s stock valued at $641,000 after buying an additional 950 shares in the last quarter. Finally, Blue Trust Inc. bought a new stake in shares of Cellebrite DI during the fourth quarter valued at approximately $468,000. Hedge funds and other institutional investors own 45.88% of the company’s stock.

Cellebrite DI Stock Performance

Shares of CLBT traded up $0.06 during trading hours on Monday, hitting $24.10. The company had a trading volume of 189,717 shares, compared to its average volume of 1,472,569. The stock has a market capitalization of $4.96 billion, a price-to-earnings ratio of -15.46, a P/E/G ratio of 3.55 and a beta of 1.47. Cellebrite DI has a 52-week low of $8.91 and a 52-week high of $24.62. The firm has a fifty day moving average price of $21.77 and a 200-day moving average price of $18.42.

Cellebrite DI (NASDAQ:CLBT) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.05. Cellebrite DI had a positive return on equity of 122.59% and a negative net margin of 82.28%. The firm had revenue of $106.90 million for the quarter, compared to analysts’ expectations of $102.06 million. During the same period in the prior year, the firm earned $0.09 EPS. The company’s revenue was up 27.0% compared to the same quarter last year. Research analysts anticipate that Cellebrite DI will post 0.32 earnings per share for the current fiscal year.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.